These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 17199818)
1. Heterozygote carrier testing in high schools abroad: what are the lessons for the U.S.? Ross LF J Law Med Ethics; 2006; 34(4):753-64. PubMed ID: 17199818 [TBL] [Abstract][Full Text] [Related]
2. Screening for carriers of Tay-Sachs disease in the ultraorthodox Ashkenazi Jewish community in Israel. Broide E; Zeigler M; Eckstein J; Bach G Am J Med Genet; 1993 Aug; 47(2):213-5. PubMed ID: 8213907 [TBL] [Abstract][Full Text] [Related]
3. Tay Sachs disease in Australia: reduced disease incidence despite stable carrier frequency in Australian Jews. Lew RM; Proos AL; Burnett L; Delatycki M; Bankier A; Fietz MJ Med J Aust; 2012 Dec; 197(11):652-4. PubMed ID: 23230938 [TBL] [Abstract][Full Text] [Related]
4. Population screening for reproductive risk for single gene disorders in Australia: now and the future. Delatycki MB Twin Res Hum Genet; 2008 Aug; 11(4):422-30. PubMed ID: 18637742 [TBL] [Abstract][Full Text] [Related]
5. A private view of heterozygosity: eight-year follow-up study on carriers of the Tay-Sachs gene detected by high school screening in Montreal. Zeesman S; Clow CL; Cartier L; Scriver CR Am J Med Genet; 1984 Aug; 18(4):769-78. PubMed ID: 6486173 [TBL] [Abstract][Full Text] [Related]
6. Assessing the potential success of cystic fibrosis carrier screening: lessons learned from Tay-Sachs disease and beta-thalassemia. Laberge AM; Watts C; Porter K; Burke W Public Health Genomics; 2010; 13(5):310-9. PubMed ID: 19864874 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of a multi-disease carrier screening programme in Ashkenazi Jewish high schools. Ioannou L; Massie J; Lewis S; Petrou V; Gason A; Metcalfe S; Aitken MA; Bankier A; Delatycki MB Clin Genet; 2010 Jul; 78(1):21-31. PubMed ID: 20597919 [TBL] [Abstract][Full Text] [Related]
8. The Tay-Sachs disease screening program in the U.S. as a model for the control of genetic disease: an historical view. Edelson PJ Health Matrix Clevel; 1997; 7(1):125-33. PubMed ID: 10167171 [No Abstract] [Full Text] [Related]
9. Cost-effectiveness of a school-based Tay-Sachs and cystic fibrosis genetic carrier screening program. Warren E; Anderson R; Proos AL; Burnett LB; Barlow-Stewart K; Hall J Genet Med; 2005 Sep; 7(7):484-94. PubMed ID: 16170240 [TBL] [Abstract][Full Text] [Related]
10. Twenty-year outcome analysis of genetic screening programs for Tay-Sachs and beta-thalassemia disease carriers in high schools. Mitchell JJ; Capua A; Clow C; Scriver CR Am J Hum Genet; 1996 Oct; 59(4):793-8. PubMed ID: 8808593 [TBL] [Abstract][Full Text] [Related]
12. [Biochemical, molecular and social aspects of carrier screening for Tay-Sachs disease]. Peleg L; Gazit E; Goldman B; Akstein E Harefuah; 1995 Dec; 129(11):475-80. PubMed ID: 8846957 [No Abstract] [Full Text] [Related]
13. The control of genetic disease by carrier screening and antenatal diagnosis: social, ethical, and medicolegal issues. Kaback MM Birth Defects Orig Artic Ser; 1982; 18(7):243-54. PubMed ID: 7159734 [No Abstract] [Full Text] [Related]
15. A genetic screening programme for Tay-Sachs disease and cystic fibrosis for Australian Jewish high school students. Barlow-Stewart K; Burnett L; Proos A; Howell V; Huq F; Lazarus R; Aizenberg H J Med Genet; 2003 Apr; 40(4):e45. PubMed ID: 12676918 [No Abstract] [Full Text] [Related]
16. Population programs for the detection of couples at risk for severe monogenic genetic diseases. Zlotogora J Hum Genet; 2009 Aug; 126(2):247-53. PubMed ID: 19390864 [TBL] [Abstract][Full Text] [Related]
17. Multimedia messages in genetics: design, development, and evaluation of a computer-based instructional resource for secondary school students in a Tay Sachs disease carrier screening program. Gason AA; Aitken M; Delatycki MB; Sheffield E; Metcalfe SA Genet Med; 2004; 6(4):226-31. PubMed ID: 15266211 [TBL] [Abstract][Full Text] [Related]